TickerFacts.

TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Cost of Revenue

Annual figures by period end, from SEC filings.

2007-12-31: $4.53B2008-12-31: $5.12B2009-12-31: $6.53B2010-12-31: $7.06B2011-12-31: $8.80B2012-12-31: $9.66B2013-12-31: $9.61B2016-12-31: $10.25B2017-12-31: $11.24B2018-12-31: $9.97B2019-12-31: $9.35B2020-12-31: $8.93B2021-12-31: $8.28B2022-12-31: $7.95B2023-12-31: $8.20B2024-12-31: $8.48B2025-12-31: $8.32B$8.32B
2007-12-31Cost of Revenue (USD)2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$8.32B-1.9%2026-02-03From 2025-01-01
2024-12-31$8.48B+3.4%2026-02-03From 2024-01-01
2023-12-31$8.20B+3.1%2026-02-03From 2023-01-01
2022-12-31$7.95B-4.0%2025-02-05From 2022-01-01
2021-12-31$8.28B-7.3%2024-02-12From 2021-01-01
2020-12-31$8.93B-4.5%2023-02-10From 2020-01-01
2019-12-31$9.35B-6.3%2022-02-09From 2019-01-01
2018-12-31$9.97B-11.2%2021-02-10From 2018-01-01
2017-12-31$11.24B+9.6%2020-02-21From 2017-01-01
2016-12-31$10.25B—2019-02-19From 2016-01-07
2013-12-31$9.61B-0.6%2014-02-10From 2013-01-01
2012-12-31$9.66B+9.9%2014-02-10From 2012-01-01
2011-12-31$8.80B+24.7%2014-02-10From 2011-01-01
2010-12-31$7.06B+8.0%2013-02-12From 2010-01-01
2009-12-31$6.53B+27.7%2012-02-17From 2009-01-01
2008-12-31$5.12B+12.9%2011-02-15From 2008-01-01
2007-12-31$4.53B—2010-02-22From 2007-01-01